TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.
This document summarizes the WHO’s review of various diagnostics for TB. Most of it is not new, but important additions are evaluation of molecular methods for detection of resistance to INH (pages 50
The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-y
Active TB Drug Safety Monitoring and Management (aDSM) global database: Outcome of the assessment and future of data reporting. Read here.